title: Using standardized fMRI protocols to identify patterns of prefrontal circuit dysregulation that are common and specific to cognitive and emotional tasks in major depressive disorder: first wave results from the iSPOT-D study.
abstract: Functional neuroimaging studies have implicated dysregulation of prefrontal circuits in major depressive disorder (MDD), and these circuits are a viable target for predicting treatment outcomes. However, because of the heterogeneity of tasks and samples used in studies to date, it is unclear whether the central dysfunction is one of prefrontal hyperreactivity or hyporeactivity. We used a standardized battery of tasks and protocols for functional magnetic resonance imaging, to identify the common vs the specific prefrontal circuits engaged by these tasks in the same 30 outpatients with MDD compared with 30 matched, healthy control participants, recruited as part of the International Study to Predict Optimized Treatment in Depression (iSPOT-D). Reflecting cognitive neuroscience theory and established evidence, the battery included cognitive tasks designed to assess functions of selective attention, sustained attention-working memory and response inhibition, and emotion tasks to assess explicit conscious and implicit nonconscious viewing of facial emotion. MDD participants were distinguished by a distinctive biosignature of: hypoactivation of the dorsolateral prefrontal cortex during working memory updating and during conscious negative emotion processing; hyperactivation of the dorsomedial prefrontal cortex during working memory and response inhibition cognitive tasks and hypoactivation of the dorsomedial prefrontal during conscious processing of positive emotion. These results show that the use of standardized tasks in the same participants provides a way to tease out prefrontal circuitry dysfunction related to cognitive and emotional functions, and not to methodological or sample variations. These findings provide the frame of reference for identifying prefrontal biomarker predictors of treatment outcomes in MDD.
authors.affiliation: The Brain Dynamics Center, University of Sydney Medical School and Westmead Millennium Institute, Sydney, NSW, Australia. M.Korgaonkar@sydney.edu.au
authors.forename: Mayuresh S
authors.initials: MS
authors.lastname: Korgaonkar
authors.forename: Stuart M
authors.initials: SM
authors.lastname: Grieve
authors.forename: Amit
authors.initials: A
authors.lastname: Etkin
authors.forename: Stephen H
authors.initials: SH
authors.lastname: Koslow
authors.forename: Leanne M
authors.initials: LM
authors.lastname: Williams
mesh_terms: D000328:Adult; D001289:Attention Deficit Disorder with Hyperactivity / Q000209:etiology*; D001931:Brain Mapping; D003072:Cognition Disorders / Q000209:etiology*; D003865:Major Depressive Disorder / Q000150:complications* / Q000473:pathology* / Q000628:therapy; D005260:Female; D006801:Humans; D007091:Image Processing, Computer-Assisted; D007391:International Cooperation; D008279:Magnetic Resonance Imaging; D008297:Male; D008570:Memory, Short-Term / Q000502:physiology; D008875:Middle Aged; D009415:Nerve Net / Q000098:blood supply*; D009483:Neuropsychological Tests; D010100:Oxygen / Q000097:blood; D011237:Predictive Value of Tests; D017397:Prefrontal Cortex / Q000098:blood supply*; D013223:Statistics as Topic
chemical_list: D010100:Oxygen